Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide
Neuro-Oncology · 2025
DOI: 10.1093/neuonc/noae275 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Geno Guerra und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Antineoplastic Agents, Alkylating, DNA Repair. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCRR NIH HHS, loglio Collective.
Abstract (Originalsprache)
Background
Temozolomide (TMZ) treatment has demonstrated a variable impact on glioma prognosis. This study examines associations of survival with DNA repair gene germline polymorphisms among glioma patients who did and did not have TMZ treatment. Identifying genetic markers which sensitize tumor cells to TMZ could personalize therapy and improve outcomes.
Methods
We evaluated TMZ-related survival associations of pathogenic germline SNPs and genetically predicted transcript levels within 34 DNA repair genes among 1504 glioma patients from the University of California San Francisco Adult Glioma Study (UCSF AGS) and Mayo Clinic, whose diagnoses spanned pre- and post-TMZ eras within the major known glioma prognostic molecular subtypes.
Results
Among those who received TMZ, 5 SNPs were associated with overall survival, but not in those who did not receive TMZ. Only rs2308321-G, in MGMT, was associated with decreased survival (hazard ratio = 1.21, P = .019) for all glioma subtypes. Rs73191162-T (near UNG), rs13076508-C (near PARP3), rs7840433-A (near NEIL2), and rs3130618-A (near MSH5) were only associated with survival and TMZ treatment for certain subtypes, suggesting subtype-specific germline chemosensitization. Genetically predicted elevated expression of PNKP, compared to normal brain expression, was associated with markedly poor survival in TMZ-treated patients with isocitrate dehydrogenase (IDH)-mutant and 1p/19q non-codeleted gliomas (P = .015), with a median difference of over 70 months in overall survival times. Similarly, NEIL2 and TDG expressions were associated with altered TMZ-related survival only among certain subtypes.
Conclusions
Functional germline alterations within DNA repair genes were associated with TMZ sensitivity, measured by overall survival among adults with glioma. These variants should be evaluated in prospective analyses and functional studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
- Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
- School of Pharmacy, University of California San Francisco, San Francisco, CA, USA.
- Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
ORCID-Profile: Geno Guerra, Lucie McCoy, Linda Kachuri, Jennie W Taylor, Robert B Jenkins, Stephen S Francis
Förderung
- NCI NIH HHS
- NCRR NIH HHS
- loglio Collective
- National Brain Tumor Society
- Centers for Disease Control and Prevention's (CDC) National Program of Cancer Registries
- National Cancer Institute's Surveillance, Epidemiology and End Results Program
- NCATS NIH HHS
- Mayo Clinic
Zitieren
APA
Guerra, G., Wendt, G., McCoy, L., Hansen, H. M., Kachuri, L., Molinaro, A. M., Rice, T., Guan, V., Capistrano, L., Hsieh, A., Kalsi, V., Sallee, J., Taylor, J. W., Clarke, J. L., Almaraz, E. R., Wiencke, J. K., Eckel-Passow, J. E., Jenkins, R. B., Wrensch, M., & Francis, S. S. (2025). Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide. Neuro-Oncology. https://doi.org/10.1093/neuonc/noae275
Vancouver
Guerra G, Wendt G, McCoy L, Hansen HM, Kachuri L, Molinaro AM, et al. Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide. Neuro-Oncology. 2025. doi:10.1093/neuonc/noae275
BibTeX
@article{Guerra2025,
author = {Guerra, Geno and Wendt, George and McCoy, Lucie and Hansen, Helen M and Kachuri, Linda and Molinaro, Annette M and Rice, Terri and Guan, Victoria and Capistrano, Lianne and Hsieh, Allison and Kalsi, Veruna and Sallee, Jaimie and Taylor, Jennie W and Clarke, Jennifer L and Almaraz, Eduardo Rodriguez and Wiencke, John K and Eckel-Passow, Jeanette E and Jenkins, Robert B and Wrensch, Margaret and Francis, Stephen S},
title = {Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide},
journal = {Neuro-Oncology},
year = {2025},
doi = {10.1093/neuonc/noae275}
}
EUVIMED